Academic Institute

Medicine & Life Sciences

1. Neoplasms 100%
2. Therapeutics 81%
3. Transplants 65%
4. Genes 62%
5. Liver Transplantation 48%
6. Kidney 46%
7. Lung 45%
8. Mortality 44%
9. Proteins 43%
10. Breast Neoplasms 42%
11. T-Lymphocytes 41%
12. Wounds and Injuries 38%
13. Survival 38%
14. Liver 37%
15. Brain 36%
16. Population 35%
17. Eye 34%
18. Coronary Vessels 33%
19. Infections 33%
20. Heart Failure 33%
21. Blood Vessels 32%
22. Cardiovascular Diseases 31%
23. Stroke 30%
24. DNA 29%
25. Safety 29%
26. Equipment and Supplies 28%
27. Magnetic Resonance Imaging 28%
28. Systematic Reviews 28%
29. Growth 28%
30. Allografts 27%
31. Atherosclerosis 27%
32. Calcium 27%
33. Coronary Artery Disease 27%
34. Heart 27%
35. Mutation 27%
36. Pharmaceutical Preparations 27%
37. In Vitro Techniques 27%
38. Post-Traumatic Stress Disorders 26%
39. Incidence 24%
40. Transplant Recipients 24%
41. Tissue Donors 24%
42. Neoplasm Metastasis 24%
43. Surgeons 23%
44. Confidence Intervals 23%
45. Biopsy 23%
46. Prostatic Neoplasms 23%
47. Drug Therapy 23%
48. Myocardial Infarction 23%
49. Health 23%
50. Registries 22%
51. Carcinoma 22%
52. Guidelines 22%
53. Gene Expression 22%
54. Polychlorinated Dibenzodioxins 22%
55. Tomography 22%
56. Apoptosis 22%
57. Transplantation 22%
58. Meta-Analysis 21%
59. Recurrence 21%
60. Technology 21%
61. Macrophages 21%
62. Inflammation 21%
63. Biomarkers 21%
64. Radiotherapy 21%
65. Phenotype 21%
66. Placebos 21%
67. Pathology 20%
68. Messenger RNA 20%
69. Pediatrics 20%
70. Skin 20%
71. Randomized Controlled Trials 20%
72. Costs and Cost Analysis 20%
73. Transcatheter Aortic Valve Replacement 19%
74. Exercise 19%
75. Clinical Trials 19%
76. Antibodies 19%
77. Parkinson Disease 19%
78. Aryl Hydrocarbon Receptors 18%
79. Serum 18%
80. Veterans 18%
81. Magnetic Resonance Spectroscopy 18%
82. Ligands 18%
83. Stem Cells 18%
84. Child 18%
85. Stents 18%
86. Genome 18%
87. Lung Neoplasms 18%
88. Fibrosis 18%
89. Adenocarcinoma 17%
90. Urinary Bladder 17%
91. Delivery of Health Care 17%
92. Injections 17%
93. Heart-Assist Devices 17%
94. Odds Ratio 17%
95. Morbidity 17%
96. Ischemia 17%
97. Animals 17%
98. Cell Line 16%
99. Prostate 16%
100. Endothelial Cells 16%